- BMJ Best Practice - Healthcare

Our robust evidence process

Over 80% of the contributors are based in the US.

Regular searches for high quality new and updated international guidelines, systematic reviews and potentially practice-changing RCTs 1

Continuous in-house scanning and triaging of drug alerts

2

Daily monitoring and triaging of user feedback by our Specialist Section Editors

Our in-house evidence team collaborates with over 1,600 international expert authors and over 2,500 peer reviewers.

3

External peer review of all new topics by at least two leading international experts and practising clinicians

4

Internal peer review and sign-off by an in-house pharmacist and senior editor

5

This ensures that your users always have access to the latest evidence-based information.

Continuous updating with changes highlighted for users

6

Powered by